tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
SUPN is currently covered by 1 analysts with an average price target of $44.07. This is a potential upside of $12.37 (39.02%) from yesterday's end of day stock price of $31.7.
Supernus Pharmaceuticals's activity chart (see below) currently has 71 price targets and 56 ratings on display. The stock rating distribution of SUPN is 75% BUY and 25% HOLD.
Analysts average stock forecasts to be materialized ratio is 65.92% with an average time for these price targets to be met of 270 days.
Highest price target for SUPN is $36, Lowest price target is $36, average price target is $36.
Most recent stock forecast was given by DAVID AMSELLEM from PIPER SANDLER on 10-Sep-2024. First documented stock forecast 11-Mar-2015.
Currently out of the existing stock ratings of SUPN, 3 are a BUY (75%), 1 are a HOLD (25%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$36
$4.3 (13.56%)
$41
8 months ago
(10-Sep-2024)
15/22 (68.18%)
$4.92 (15.83%)
130
Buy
$44
$12.3 (38.80%)
$40
3 years 5 months 10 days ago
(30-Nov-2021)
12/15 (80%)
$13.15 (42.63%)
241
Hold
$23
5 years 25 days ago
(15-Apr-2020)
5/7 (71.43%)
$1.85 (8.75%)
100
Buy
$65
$33.3 (105.05%)
$65
6 years 3 months 13 days ago
(27-Jan-2019)
3/5 (60%)
$28.85 (79.81%)
225
Buy
$57
$32.69 (134.47%)
6 years 5 months 20 days ago
(21-Nov-2018)
1/2 (50%)
$13.06 (49.50%)
654
What is SUPN (Supernus Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on SUPN (Supernus Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on SUPN (Supernus Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on SUPN (Supernus Pharmaceuticals)?
Which analyst is the currently most bullish on SUPN (Supernus Pharmaceuticals)?
Which analyst is the currently most reserved on SUPN (Supernus Pharmaceuticals)?
